Cellular maturation defects in Bruton's tyrosine kinase-deficient immature B cells are amplified by premature B cell receptor expression and reduced by receptor editing
January 2004
Article
| Related Files |
|---|
|
(14734712.pdf, 0.5MB) |
In the mouse, Bruton's tyrosine kinase (Btk) is essential for efficient developmental progression of CD43(+)CD2(-) large cycling into CD43(-)CD2(+) small resting pre-B cells in the bone marrow and of IgM(high) transitional type 2 B cells into IgM(low) mature B cells in the spleen. In this study, we show that the impaired induction of cell surface changes in Btk-deficient pre-B cells was still noticeable in kappa(+) immature B cells, but was largely corrected in lambda(+) immature B cells. As lambda gene rearrangements are programmed to follow kappa rearrangements and lambda expression is associated with receptor editing, we hypothesized that the transit time through the pre-B cell compartment or receptor editing may affect the extent of the cellular maturation defects in Btk-deficient B cells. To address this issue, we used 3-83 mu delta transgenic mice, which prematurely express a complete B cell receptor and therefore manifest accelerated B cell development. In Btk-deficient 3-83 mu delta mice, the IgM(+) B cells in the bone marrow exhibited a very immature phenotype (pre-BCR(+)CD43(+)CD2(-)) and were arrested at the transitional type 1 B cell stage upon arrival in the spleen. However, these cellular maturation defects were largely restored when Btk-deficient 3-83 mu delta B cells were on a centrally deleting background and therefore targeted for receptor editing. Providing an extended time window for developing B cells by enforced expression of the antiapoptotic gene Bcl-2 did not alter the Btk dependence of their cellular maturation. We conclude that premature B cell receptor expression amplifies the cellular maturation defects in Btk-deficient B cells, while extensive receptor editing reduces these defects.
- Animals
- Comparative Study
- Research Support, Non-U.S. Gov't
- Mice
- Mice, Knockout
- Mice, Transgenic
- Mice, Inbred C57BL
- Cells, Cultured
- Cell Differentiation/genetics/immunology
- B-Lymphocyte Subsets/enzymology/immunology/metabolism/*pathology
- Cell Movement/genetics/immunology
- Clonal Deletion/genetics
- Down-Regulation/genetics/*immunology
- Gene Rearrangement, B-Lymphocyte/genetics/*immunology
- Hematopoietic Stem Cells/*enzymology/immunology/pathology
- Immunoglobulin delta-Chains/genetics
- Immunoglobulin kappa-Chains/biosynthesis
- Immunoglobulin mu-Chains/genetics
- Lymphopenia/enzymology/genetics/immunology/pathology
- Membrane Glycoproteins/*biosynthesis/metabolism
- Protein-Tyrosine Kinase/biosynthesis/*deficiency/genetics
- Proto-Oncogene Proteins c-bcl-2/biosynthesis/genetics
- Receptors, Antigen, B-Cell/*biosynthesis/genetics
- Spleen/immunology/pathology
- Up-Regulation/genetics/*immunology
- Immunoglobulin lambda-Chains/biosynthesis
- b cells
- 3-83
- expression
- btk 3-83 mice
- b cell development
- receptor editing
- pre-b
- btk-deficient
- receptor
- spleen
- editing
- maturation
- development
- btk-deficient mice
- pre-b cells
- defect
- number
- marker
- maturation defects
- chain